Dr. John Cush RheumNow
3 years 2 months ago
Excessive alcohol intake associated with higher risks of 61 diseases in men, including liver cirrhosis, stroke, and several gastrointestinal cancers, gout, cataracts, some fractures, and gastric ulcer. https://t.co/WqMuHQ3Unn https://t.co/IU0SaRcswZ
Dr. John Cush RheumNow
3 years 2 months ago
519 pts in the Hand OSTeoArthritis in Secondary care (HOSTAS) cohort studied & 17% had prolonged morning stiffness (>60 min); mild in 30%, intermediate in 37%, severe in 18% and extreme in 4%. Assoc w/ more pain, worse function and QOL https://t.co/6LSir7nSae https://t.co/lhoxwpfuqD
Dr. John Cush RheumNow
3 years 2 months ago
Study of 162axSpA pts found that 46.6% reported abnormal sleep behavior, worse in Female patients vs males (P <.001). Such pts were more likely to have depression (P = .015) and worse health-related QoL (HRQOL) (P = .015) https://t.co/a1OoUTPKiV https://t.co/gkjkkdljOh
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com, including new drug approval, a new SpA variant and new rules for methotrexate (MTX) monitoring and depression screening.
The American College of Rheumatology (ACR) today expressed disappointment that the Medicare Payment Advisory Commission (MedPAC) has recommended yet another cut to physician reimbursement for infusing life-altering treatments as part of its June 2023 Report to the Congress: Medicare and the Health Care Delivery System.
A Korean study of a large systemic lupus erythematosus (SLE) cohort shows by genomic analysis, that higher weighted genetic risk scores (wGRS) is associated with earlier SLE onset, higher anti–Sm antibody positivity, lupus nephritis and more diverse lupus manifestations.
Dr. John Cush RheumNow
3 years 2 months ago
Study of 2883 pediatric patients with Hidradenitis Supprativa (HS), finds a higher risk of Crohns disease - 0.69% of HS and 0.17% of control patients developed CD (OR 4.90, 3.07-7.84; P < .001) higher in patients with HS than in control patients. https://t.co/gcfT4CET5h https://t.co/vQIzIzwsmn
Dr. John Cush RheumNow
3 years 2 months ago
We should put the CART before the T in SLE!
Dr. Janet Pope ( @Janetbirdope ) reports from EULAR 2023 in Milan, Italy.
https://t.co/HwYphsg3ad https://t.co/Ghu2M6yaFn
Dr. John Cush RheumNow
3 years 2 months ago
Still's Disease Abstracts at EULAR 2023
https://t.co/1gNf8RUDLi https://t.co/1f1ERUOS03
Dr. John Cush RheumNow
3 years 2 months ago
WATCH: Update on CAR T-Cell Therapy in SLE & Autoimmune Diseases
Dr. Peter Nash reporting from EULAR 2023 in Milan, Italy.
https://t.co/r5cMWYHk9A https://t.co/8Si1kUmzAs
Dr. John Cush RheumNow
3 years 2 months ago
EULAR 2023 Day 4 Recap
Join Drs. Jack Cush, David Liew and Bella Mehta as they recap data presented on Day 4 at EULAR 2023 in Milan, Italy.
https://t.co/3VP1dB6YHp https://t.co/mSBB3bDWRl
Dr. John Cush RheumNow
3 years 2 months ago
Diagnostic Yield of Cranial and Large Vessel Imaging in GCA
Combined cranial and large vessel ultrasound and PET/CT provided excellent accuracy for the diagnosis of giant cell arteritis (GCA).
https://t.co/0gBXXLy1db https://t.co/zp12wZIkqL
Dr. John Cush RheumNow
3 years 2 months ago
EULAR Offers Tips on Psoriasis Progression to PsA
Clinicians treating patients with psoriasis should be on the lookout for certain signs that joint involvement is likely to develop, according to a new "points to consider" from the EULAR.
https://t.co/JP7OjpYtBe https://t.co/HMFkzMGOFO
